Relmada Therapeutics, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2020 | 16.3M |
| FY2021 | 17.6M |
| FY2022 | 29.6M |
| FY2023 | 30.1M |
| FY2024 | 30.2M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2020 | 16.3M |
| FY2021 | 17.6M |
| FY2022 | 29.6M |
| FY2023 | 30.1M |
| FY2024 | 30.2M |